Andy Knight
@AndyKnightMD
Followers
320
Following
1K
Media
11
Statuses
135
Chief IM Resident | UPMC | @PittGIM | Future Oncologist | #Melanoma | #Immunotherapy
Pittsburgh, PA
Joined September 2022
I matched at @DanaFarber for Heme/Onc fellowship!!! I cannot express how excited I am! Thank you to my incredible mentors and everyone who supported me through this process. I can't wait for this next chapter. @KarapetLilit @jmkirkwood @YanaNajjarMD @LenAppleman @jasonlukemd
24
5
416
RT @diwakardavar: Excellent presentation by @MeghanMooradian from.@DFCI presenting @UPMCHillmanCC led Neo-Mel-T trial evaluating neoadjuvan….
0
4
0
Join us tomorrow for virtual morning report!.
#MedTwitter - Grab your morning coffee and plan your week with us!☕️. We can't wait to see you at this week's sessions!🙂. Join our live sessions for free using the link➡️
0
0
4
RT @jasonlukemd: Extremely excited re: IMA203 - PRAME TCR T cells Ph 1 study published in @NatureMedicine! This is a transformative Rx in #….
0
61
0
Come join Dr. Vidula from @MGHBreastOnc and me for @CPSolvers morning report!.
#MedTwitter - Plan your week with us! . We have an exciting week ahead here at Clinical Problem Solvers. Join our live sessions for free using the link➡️
0
3
9
RT @HMAbushukair: Check out our recent work on TLS and their overshadowed precursors, lymphoid aggregate, in melanoma out now in @jitcancer….
0
4
0
RT @OmidHamidMD: Jeffrey S Weber's life is a testament to mentorship, patient care, sacrifice, leadership. Thank you @jitcancer for allowin….
0
37
0
RT @DrBetofMDPhD: We lost a legend today. Jeff meant so much to the fields of melanoma and immuno-oncology. We were fortunate to learn from….
0
13
0
RT @tonyrcillo: Excited to share our paper out today in @CellCellPress with @BcellBruno @Vignali_Lab! Part of a trio of papers, we show in….
0
21
0
RT @SabrinaBruno_: Had a great time at #ASCO24 this year! Thank you to my wonderful mentors @AndyKnightMD and @jmkirkwood for the support a….
0
4
0
RT @jasonlukemd: Nice review here on recent advancements for #melanoma developmental #immunotherapy. Great work @AndyKnightMD! Useful read….
0
6
0
RT @PittIMChiefs: This is the face of very proud @PittIMChiefs @AndyKnightMD, @CaseySkittle, @valenjaramillo7 and PD @ACarterMD after witne….
0
3
0
RT @ACarterMD: Outgoing and incoming @PittIMChiefs chief residents at #AIMW24!! So proud of these amazing humans. @PittGIM @PittDeptofMed….
0
5
0
RT @CureMelanoma: "My research aims to uncover any differences in treatment outcomes among patients with pre-existing type II diabetes at t….
0
8
0
RT @UPMCHillmanCC: Published in @JCO_ASCO, Dr. Jason Luke (@jasonlukemd) shares a three year update for the KEYNOTE-716 study. These result….
0
4
0
RT @LenAppleman: Thanks, @DrChoueiri; and to the patients & study team, @eaonc @SWOG @ALLIANCE_org @montypal @neerajaiims @BrianCostelloMD….
0
6
0
RT @DrBetofMDPhD: Lifileucel (TIL cell therapy from @IovanceBio) is now FDA approved for advanced PD-1 refractory melanoma!!! The melanoma….
0
46
0
RT @PittIMChiefs: Another successful Medicine Grand Rounds on the books. You all make us proud and it is an absolute pleasure to witness ea….
0
5
0
RT @PittDeptofMed: 🗓️ Join us at noon on Tuesday, 12.12.23, for the next DOM Grand Rounds! . Tuesday's MGR will feature research presentat….
0
7
0
RT @PittIMChiefs: To all of our residents/recent grads that recently match to different fellowships, CONGRATULATIONS!!! We are proud and ex….
0
10
0